HOLX
Hologic·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 0
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About HOLX
Hologic, Inc.
A leading medical technology company that develops and manufactures diagnostic products and surgical equipment
Healthcare Equipment and Supplies
--
03/02/1990
NASDAQ Stock Exchange
7,070
09-30
Common stock
250 Campus Drive, Marlborough, Massachusetts 01752
--
Hologic, Inc., was incorporated in Massachusetts in October 1985 and re-incorporated in Delaware in March 1990. The Company is a developer, manufacturer and supplier of advanced diagnostic products, medical imaging systems and surgical products focused on safeguarding the health and well-being of women through early detection and treatment.
Earnings Call
Company Financials
EPS
HOLX has released its 2025 Q4 earnings. EPS was reported at 1.13, versus the expected 1.1, beating expectations. The chart below visualizes how HOLX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
HOLX has released its 2025 Q4 earnings report, with revenue of 1.05B, reflecting a YoY change of 6.24%, and net profit of 187.30M, showing a YoY change of 4.87%. The Sankey diagram below clearly presents HOLX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


